Literature DB >> 7722650

The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens.

N Ladurelle1, B P Roques, V Daugé.   

Abstract

The effects of cholecystokinin octapeptide (CCK8) on extracellular dopamine (DA) and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, were measured in the nucleus accumbens (N. Acc.). The experiments were carried out using in vivo microdialysis in awake rats submitted, or not, to a novel environment, the four-hole box. The exploratory behavior of the animals was studied concurrently in these boxes and in the elevated plus maze. Without CCK8 treatment, the transfer of animals from their home cages to the four-hole box induced a transient increase in DA efflux and also tended to increase its metabolites in the posterior N. Acc. In rats placed in a familiar environment, the administration of 25 pmol of CCK8 in this region immediately enhanced DA release, with levels rapidly returning to normal at the end of the perfusion. In contrast, this treatment produced a longer effect in rats transferred to the four-hole box, since the DA efflux was still increased 80 min after the removal of CCK8. The intra-accumbal administration of CCK8 induced a hypoexploration in the four-hole box. Moreover, an anxiogenic-like effect of CCK8 was found in the elevated plus maze, only in rats submitted to a novel environment (four-hole box). These data show that (1) the postero-accumbens DA neurons can be activated by environmental changes and (2) that the intensity of the CCK8 effects on extracellular DA levels and on anxiety-like responses seems to depend on the activity of these neurons previous to CCK8 treatment. The prolonged DA release induced by CCK8 in animals placed in a new situation could correspond to a biochemical anticipation preparing them to react when faced by another stimulus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722650      PMCID: PMC6577787     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  7 in total

1.  The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release.

Authors:  Jérémie Neasta; Charlène Valmalle; Anne-Claire Coyne; Eric Carnazzi; Gilles Subra; Jean-Claude Galleyrand; Didier Gagne; Céline M'Kadmi; Nicole Bernad; Gilbert Bergé; Sonia Cantel; Philippe Marin; Jacky Marie; Jean-Louis Banères; Marie-Lou Kemel; Valérie Daugé; Karine Puget; Jean Martinez
Journal:  Br J Pharmacol       Date:  2016-03-08       Impact factor: 8.739

2.  Increased mesocorticolimbic dopamine during acute and repeated social defeat stress: modulation by corticotropin releasing factor receptors in the ventral tegmental area.

Authors:  Elizabeth N Holly; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-09-25       Impact factor: 4.530

3.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

4.  The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses.

Authors:  Santiago J Ballaz; Huda Akil; Stanley J Watson
Journal:  Neuropeptides       Date:  2008-04-14       Impact factor: 3.286

5.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

Review 6.  Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review.

Authors:  Vasilios G Masdrakis; David S Baldwin
Journal:  Ther Adv Psychopharmacol       Date:  2021-03-21

7.  A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.

Authors:  James M Prosser; Samantha Yard; Annie Steele; Lisa J Cohen; Igor I Galynker
Journal:  BMC Psychiatry       Date:  2009-05-26       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.